AP Pharma has received a $2.5 million milestone payment from an affiliate of the Paul Royalty Fund for two dermatology drugs, the specialty pharmaceutical company said.
From: www.pharmaceutical-business-review.com
AP Pharma receives $2.5 million from skin drug sales
Posted by Ruslan Abuzant at 9:44 PM
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment